Danapha Pharmaceutical JSC (HSTC:DAN) Net Margin %: 0.00% (As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
30 GF Score
Price ₫30,300.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC Net Margin %?

Danapha Pharmaceutical JSC HSTC:DAN 30 Net Margin % is 0.00% as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 956 Drug Manufacturers companies, Danapha Pharmaceutical JSC ranks worse than 104602.41% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Danapha Pharmaceutical JSC's Net Income for the six months ended in . 20 was ₫0.00 Mil. Danapha Pharmaceutical JSC's Revenue for the six months ended in . 20 was ₫0.00 Mil. Therefore, Danapha Pharmaceutical JSC's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Danapha Pharmaceutical JSC's Net Margin % or its related term are showing as below:


HSTC:DAN's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.56
* Ranked among companies with meaningful Net Margin % only.

Danapha Pharmaceutical JSC  (HSTC:DAN) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Danapha Pharmaceutical JSC Net Margin % Related Terms

Danapha Pharmaceutical JSC Net Margin % Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC Net Margin % Chart

Danapha Pharmaceutical JSC Annual Data
Trend
Net Margin %

Danapha Pharmaceutical JSC Semi-Annual Data
Net Margin %

HSTC:DAN vs ZTS, UTHR, VTRS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Danapha Pharmaceutical JSC's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Danapha Pharmaceutical JSC Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Danapha Pharmaceutical JSC's Net Margin % distribution charts can be found below:

* The bar in red indicates where Danapha Pharmaceutical JSC's Net Margin % falls into.


HSTC:DAN
30GF Score
Danapha Pharmaceutical JSC HSTC:DAN
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Danapha Pharmaceutical JSC's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Danapha Pharmaceutical JSC's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Danapha Pharmaceutical JSC and its competitors. According to the industry distribution chart, Danapha Pharmaceutical JSC ranks #999999 out of 956 companies in the Drug Manufacturers industry.
Is Danapha Pharmaceutical JSC's Net Margin % too high?
Danapha Pharmaceutical JSC's current Net Margin % is 0.00%. Based on the distribution chart, Danapha Pharmaceutical JSC ranks #999999 out of 956 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Danapha Pharmaceutical JSC ranks #999999 out of 956 companies for Net Margin %. This places Danapha Pharmaceutical JSC in the lower half of its industry. The industry median Net Margin % is 5.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Danapha Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Danapha Pharmaceutical JSC's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Danapha Pharmaceutical JSC's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
30GF Score

Get the complete analysis for HSTC:DAN

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,300.00
Price